BRIEF-Glaxosmithkline reports 9.3% passive stake in Regulus Therapeutics

Published 3:45 PM ET Sun, 11 Nov 2012

Oct 10 (Reuters) - Regulus Therapeutics Inc :

* Glaxosmithkline plc reports 9.3% passive stake in Regulus Therapeutics Inc

as of October 3 - SEC filing

* Source text: * Further company coverage ((Bangalore Newsroom; +1 646 223 8780))

Related Securities

Symbol	Price		Change	%Change
GSK		---